Please login to the form below

Not currently logged in

Fresenius Kabi Oncology

This page shows the latest Fresenius Kabi Oncology news and features for those working in and with pharma, biotech and healthcare.

Two blood cancer drugs among CHMP recommendations

Two blood cancer drugs among CHMP recommendations

The CHMP also granted positive opinions to Fresenius' generic version of the chemotherapy busulfan and to a biosimilar version of Amgen's Neupogen to be marketed by Accord. ... The final recommendation was for a generic version of busulfan to be marketed

Latest news

  • GSK loses patent on Tykerb in India GSK loses patent on Tykerb in India

    A bid to overturn the patent - filed by New Delhi-based Fresenius Kabi Oncology Ltd - was upheld by India's Intellectual Property Appellate Board (IPAB) last week, opening the door to

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....